Synthetic Biology and the “Bioeconomy”: Feeding Fuel to the Fire of Landgrabs and
Biodiversity Loss
By Eric Hoffman and Jeff Conant,
Global Forest Coalition
| 02. 14. 2013
[For footnotes, see here]
The industrial revolution replaced wood for fossil fuels as the driver of the engine of progress, leaving living plants to take a back seat in energy production. Now, with the advent of a set of technologies known as synthetic biology, industry groups and the US Department of Energy are celebrating the advent of a new “bioeconomy” – an energy and materials economy in which products and processes previously derived from petroleum will be produced through the exploitation of biomass and biotechnology. By employing the rapidly expanding techniques of synthetic biology, the new industrialists want to turn microbes into “living chemical factories” engineered to produce substances they would not produce naturally, such as biofuels, bio-plastics, industrial chemicals and oils, and even medicines.
However, early indications show that such an approach likely harbors all of the ill-effects of the fossil fuel economy – simply swapping out black carbon for green – combined with the assault on biodiversity brought on by biotechnologies such as genetic engineering of crops. Humans have already caused a state-shift in the global ecosystem...
Related Articles
By Emma McDonald Kennedy
| 10.29.2026
At the beginning of Nathan Fielder and Lance Oppenheim’s blockbuster documentary You Can See Everything, Billy Evans (partner of Theranos founder and convicted fraudster Elizabeth Holmes), says that they decided to do the film for one purpose: “radical transparency.” As they work on “Theranos 2.0,” Evans and Holmes want to show the public that she has been misunderstood –– painted as a liar and a fraud in the public imagination (and the courts) despite, as she claims in the...
By Jonquilyn Hill, Vox | 10.18.2026
By Roxanne Khamsi, The Atlantic | 10.16.2026
In recent months, news came out about several distressing cases that have underscored the risks of gene therapy, which delivers DNA to a patient’s cells to treat disease. All of these cases have one thing in common that’s not apparent...
By Rebecca Roberts, The Scientist | 10.11.2026
Heritable genome editing in human embryos is once again under intense scrutiny after the publication of an opinion piece in Trends in Genetics at the end of last month.1 In the paper, Cathy Tie, the founder and chief...